Pharmaceutical Research

, Volume 8, Issue 1, pp 97–100

Mechanism of Gastric Emptying of a Nondisintegrating Radiotelemetry Capsule in Man

  • Parviz Mojaverian
  • James C. Reynolds
  • Ann Ouyang
  • Fern Wirth
  • Paul E. Kellner
  • Peter H. Vlasses
Article

Abstract

We studied the mechanism of gastric emptying of a pH-sensitive radiotelemetry capsule with respect to phases of the interdigestive migrating motor complex (IMMC) in fasting normal volunteers and the effect of the Heidelberg capsule (HC) on the duration or timing of the IMMC phases. A manometric catheter with eight mounted solid-state strain gauges was passed transnasally and positioned fluoroscopically in the duodenum and jejunum in four normal, fasted male volunteers, in their right lateral position. The HC was administered orally following the establishment of one complete IMMC cycle (defined by the recording time between the end of two subsequent phase III activity fronts) and during the beginning of Phase I of the next cycle. The gastric residence time (GRT) of the HC was measured as the time of a gastric pH rise of ≥3.0 units. In three subjects, GRT of the HC lasted to within 5 min of the onset of the next duodenal phase III of the IMMC, while in the fourth subject, the HC passed during the second phase III activity front. There were no significant differences in the duration of each phase of duodenal IMMC in the presence or absence of the HC (Phase I, 54 ± 9.3 vs 31.6 ± 10.1; Phase II, 22 ± 8.1 vs 58.9 ± 32; Phase III, 5.3 ± 0.7 vs 4.2 ± 0.7 min; mean ± SE; P > 0.1 in all phases). In addition, the HC had no effect on motility index or patterns of contractions. The Heidelberg radiotelemetry device (7 × 20 mm) may be used as a noninvasive, nonradioactive means of measuring the activity of the IMMC and the presence of Phase III peak IMMC activity. Further, it permits detailed evaluation of the emptying patterns of solid dosage forms (i.e., enteric-coated tablet or controlled-release matrix) in humans under fasted or fed conditions.

Heidelberg capsule radiotelemetry technique manometry recording Phase III of interdigestive migrating motor complex (IMMC) indigestible solid capsule gastric residence time pH-sensitive device gastric and intestinal IMMC 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    R. A. Hinder and K. E. Kelly. Am. J. Physiol. 233:E335–E340 (1977).Google Scholar
  2. 2.
    H. Minami and W. McCallum. Gastroenterology 86:1592–1610 (1984).Google Scholar
  3. 3.
    K. A. Kelly. Am. J. Physiol. 239:G71–G76 (1980).Google Scholar
  4. 4.
    K. A. Kelly. In J. R. Johnson (ed.), Physiology and the Gastrointestinal Tract, Raven, New York, 1981, pp. 393–410.Google Scholar
  5. 5.
    Z. Itoh, I. Aizawa, and T. Sekiguchi. Clin. Gastroenterol. 11:497–521 (1982).Google Scholar
  6. 6.
    A. Ouyang, A. G. Sunshine, and J. C. Reynolds. Digest. Dis. Sci. 34:528–536 (1989).Google Scholar
  7. 7.
    A. M. Connell and T. E. Waters. Lancet 2:227–230 (1964).Google Scholar
  8. 8.
    M. R. Andres and J. R. Bingham. Can. Med. Assoc. J. 102:1087–1089 (1970).Google Scholar
  9. 9.
    E. Johannesson, P. O. Magnusso, N. O. Sjaberg, and A. Skovjens. Scand. J. Gastroenterol. 8:65–69 (1973).Google Scholar
  10. 10.
    P. Mojaverian, R. K. Ferguson, P. H. Vlasses, M. L. Rocci, Jr., A. Oren, J. A. Fix, L. J. Caldwell, and C. Gardner. Gastroenterology 89:392–397 (1985).Google Scholar
  11. 11.
    P. Mojaverian, M. L. Rocci, Jr., D. P. Conner, W. B. Abrams, and P. H. Vlasses. Clin. Pharmacol. Ther. 41:11–17 (1987).Google Scholar
  12. 12.
    M. L. Rocci, Jr., P. Mojaverian, R. J. Davis, R. K. Ferguson, and P. H. Vlasses. Clin. Pharmacol. Ther. 42:45–49 (1987).Google Scholar
  13. 13.
    P. Mojaverian, P. H. Vlasses, P. E. Kellner, and M. L. Rocci, Jr. Pharm. Res. 5:639–644 (1988).Google Scholar
  14. 14.
    P. Mojaverian, K. Chan, A. Desai, and V. John. Pharm. Res. 6:719–724 (1989).Google Scholar
  15. 15.
    P. Mojaverian and K. Chan. Pharm Res. 5:S-243 (1988) (abstr.).Google Scholar
  16. 16.
    E. Hunter, J. T. Fell, and H. Sharma. Int. J. Pharm. 17:59–64 (1983).Google Scholar
  17. 17.
    T. Itoh, T. Higuchi, C. R. Gardner, and L. Caldwell. J. Pharm. Pharmacol. 38:801–806 (1986).Google Scholar
  18. 18.
    M. Feldman, H. J. Smith, and T. R. Simon. Gastroenterology 87:895–902 (1984).Google Scholar
  19. 19.
    J. E. Kellow, T. J. Borody, S. F. Phillips, R. L. Tucker, and A. C. Haddad. Gastroenterology 91:386–395 (1986).Google Scholar
  20. 20.
    D. G. Thompson, D. L. Wingate, L. Archer, M. J. Benson, W. J. Green, and R. J. Hardy. Gut 21:500–506 (1980).Google Scholar
  21. 21.
    P. Kerlin and S. F. Phillips. Gastroenterology 82:694–700 (1982).Google Scholar
  22. 22.
    R. Burn-Murdoch, M. A. Fisher, and J. N. Hunt. J. Physol. 302:395–398 (1980).Google Scholar
  23. 23.
    K. Heinkel. J. Int. Med. Res. 2:39–46 (1974).Google Scholar
  24. 24.
    W. S. Nimmo. Clin. Pharmacokin. 1:189–203 (1976).Google Scholar
  25. 25.
    K. Chan, P. Mojaverian, K. Vyas, B. Ziehmer, and V. John. Pharm. Res. 6:S-162 (1989) (abstr.).Google Scholar
  26. 26.
    K. Chan, P. Mojaverian, K. Vyas, B. Ziehmer, and V. John. Pharm. Res. 6:S-157 (1989) (abstr.).Google Scholar
  27. 27.
    P. Mojaverian, S. Parker, C. Warner, and P. H. Vlasses. Clin. Pharmacol. Ther. 47:382–388 (1990).Google Scholar
  28. 28.
    V. I. Vashi and M. C. Meyer. J. Pharm. Sci. 77:760–764 (1988).Google Scholar
  29. 29.
    A. B. Straughn, C. J. Betlach, M. C. Meyer, E. J. Jarvi, and M. A. Gonzalez. Pharm. Res. 4:S-80 (1987) (abstr.).Google Scholar
  30. 30.
    C. Y. Lui, R. Oberle, D. Fleisher, and G. L. Amidon. J. Pharm. Sci. 75:469–474 (1986).Google Scholar
  31. 31.
    J. B. Dressman and G. L. Amidon. J. Pharm. Sci. 73:935–938 (1984).Google Scholar
  32. 32.
    L. Kaus, H. Sharma, and J. T. Fell. J. Pharm. Pharmacol. 36:136–138 (1984).Google Scholar
  33. 33.
    D. L. Cassey, R. M. Beihn, G. A. Digenis, and M. B. Shambhu. J. Pharm. Sci. 65:1412–1413 (1976).Google Scholar
  34. 34.
    C. G. Wilson, G. D. Parr, J. W. Kennerley, M. J. Taylor, S. S. Davis, J. G. Hardy, and J. A. Rees. Int. J. Pharm. 18:1–8 (1984).Google Scholar
  35. 35.
    A. Parr and M. Jay. Pharm. Res. 4:524–526 (1987).Google Scholar
  36. 36.
    A. F. Parr, G. A. Digenis, E. P. Sandefer, I. Ghebre-Sellassie, U. Iyer, R. U. Nesbitt, and B. M. Scheinthal. Pharm. Res. 7:264–269 (1990).Google Scholar
  37. 37.
    C. A. Youngberg, R. R. Berardi, W. F. Howatt, M. L. Hyneck, G. L. Amidon, J. H. Meyer, and J. B. Dressman. Digest. Dis. Sci. 32:472–480 (1987).Google Scholar
  38. 38.
    P. Mojaverian, S. Parker, C. Warner, and P. H. Vlasses. Clin. Pharmacol. Ther. 45:183 (1989) (abstr.).Google Scholar
  39. 39.
    P. Mojaverian, J. C. Reynolds, P. H. Vlasses, F. Wirth, and A. Ouyang. Pharmacologist 30:A139 (1988) (abstr.).Google Scholar
  40. 40.
    S. J. Gordon, P. Mojaverian, P. E. Kellner, and P. H. Vlasses. Gastroenterology 92:1410 (1987) (abstr.).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • Parviz Mojaverian
    • 1
  • James C. Reynolds
    • 3
  • Ann Ouyang
    • 3
  • Fern Wirth
    • 3
  • Paul E. Kellner
    • 1
  • Peter H. Vlasses
    • 1
  1. 1.Division of Clinical PharmacologyJefferson Medical CollegePhiladelphia
  2. 2.Schering-Plough Research, (B-6-125)Bloomfield
  3. 3.Gastrointestinal Section, Department of MedicineUniversity of PennsylvaniaPhiladelphia

Personalised recommendations